Quick answer.
Finasteride blocks one of the two enzymes that convert testosterone into DHT. Dutasteride blocks both. On paper, dutasteride lowers DHT more — and in head-to-head studies, it tends to produce slightly better hair regrowth. In practice, finasteride is the standard first-line treatment for most men because the difference is incremental, the side-effect profiles are broadly similar, and finasteride has the longer track record. Dutasteride is usually considered when finasteride has not delivered enough, or when a man and clinician decide the marginal benefit is worth it.
Most men who get into the weeds on hair loss treatments hit the same fork in the road eventually. Finasteride is the first thing the doctor mentions. Dutasteride is the one a forum thread or a friend on Reddit swears is stronger. Then comes the question of whether stronger is the same as better, and whether the upgrade is worth whatever extra trade-off comes with it.
The answer, like most answers in medicine, is that it depends. The two drugs are first cousins, not unrelated medications. They work on the same hormonal pathway. They produce results in the same general ballpark. The differences are real but usually smaller than the way the internet talks about them suggests.
Here is what is actually going on under the hood, what the head-to-head trial data looks like, where the side-effect picture lines up and where it does not, and why finasteride remains the default for most men even when dutasteride is technically more potent.
Dutasteride vs finasteride: quick comparison
Finasteride and dutasteride are both 5-alpha-reductase inhibitors. They work by blocking the enzyme that turns testosterone into DHT, which is the hormone that miniaturizes hair follicles in androgenic alopecia. Lower DHT means slower follicle damage and, in many men, partial regrowth.
The headline difference is which version of the enzyme each drug blocks. Finasteride targets only the type 2 isoenzyme. Dutasteride targets both type 1 and type 2. The result is that dutasteride tends to suppress DHT more deeply — by around 90 percent or more, compared to roughly 70 percent for finasteride. That is a real gap. Whether it shows up in your hairline as a bigger gap is a different question, and the answer depends on factors that have nothing to do with the math.
How finasteride works for hair loss
Finasteride is the medication most men think of when they think of prescription hair loss treatment. It has been FDA-approved for male pattern baldness since 1997, originally as Propecia and now widely available as a generic. The standard dose for hair loss is 1mg daily.
Mechanism is straightforward in principle. Block the type 2 isoenzyme of 5-alpha-reductase, lower DHT by about two-thirds, give the follicles a break from the hormonal pressure that has been gradually shutting them down. Most men see shedding slow within three to six months. Visible regrowth tends to show up between months six and twelve. The effect is maintained as long as the medication is taken consistently. Stop, and DHT climbs back to baseline within weeks; the hair that returned over months will eventually reverse.
Finasteride has the longer track record in real-world use, the deeper bench of long-term safety data, and the lowest cost. Combining it with minoxidil is the modern standard for men who want a stronger response than either drug alone tends to produce.
How dutasteride works for hair loss
Dutasteride was developed for benign prostatic hyperplasia (BPH) and is FDA-approved for that indication, not for hair loss. Its use for androgenic alopecia is off-label in the US, though it is approved for male pattern baldness in South Korea and Japan, where it has been used clinically for years.
It blocks both type 1 and type 2 isoenzymes of 5-alpha-reductase, which is the part of the molecule that drives the bigger DHT reduction. The standard dose for hair loss is 0.5mg daily. Onset is roughly the same as finasteride — months, not weeks — but the steady-state DHT suppression is deeper. PubMed indexes the off-label clinical literature for anyone who wants to read the actual trial data.
One mechanical detail worth flagging: dutasteride has a much longer half-life than finasteride. Roughly five weeks, compared to around six hours. That is not the kind of number that affects daily dosing, but it matters if a man stops the drug — DHT does not bounce back overnight. It also matters for how side effects, when they occur, can take longer to clear.
Which is stronger for blocking DHT?
Dutasteride is. The question is whether that translates into a meaningful real-world difference, and the answer is sometimes yes, sometimes barely.
In a 2014 head-to-head trial comparing 0.5mg dutasteride against 1mg finasteride, dutasteride produced more hair count growth at 24 weeks. The difference was statistically significant but modest in absolute terms — about 12 to 15 additional hairs per centimeter squared on average, depending on the measurement window. Subsequent meta-analyses have shown a similar pattern: dutasteride tends to outperform finasteride on average, but the gap is incremental rather than transformative.
What this looks like in a real man's hairline is variable. Some men respond strongly to one and weakly to the other. Some respond to both equally. The 30-percent-stronger DHT suppression on paper does not always show up as a 30-percent-better outcome in the mirror, because hair regrowth depends on more than the depth of the DHT reduction — follicle viability, age, scalp inflammation, baseline vascular health, and minoxidil status all matter.
Dutasteride vs finasteride results
The honest summary of the results literature is that men who respond well to either drug tend to respond well, full stop, and the choice between them is rarely the variable that determines a good or bad outcome.
Finasteride results in a typical responder: shedding slows by month three, hair count stabilizes by month six, modest regrowth becomes visible between months six and twelve, and the result holds as long as the drug is continued. Most men see preservation more reliably than regrowth — the medication is better at stopping further loss than at restoring what is already gone.
Dutasteride results in a typical responder: similar timeline, with somewhat more regrowth on average and somewhat more density at the crown specifically. The hairline tends to respond less to either drug than the crown does, which is true across both medications.
What changes the results conversation more than the choice of 5-alpha-reductase inhibitor is whether minoxidil is added, whether the man is consistent (this is the silent killer of hair loss treatment), and how early in the process treatment starts. A man on consistent finasteride plus minoxidil will usually outperform a man on inconsistent dutasteride. The drug is not the variable.
Dutasteride vs finasteride side effects
The side-effect profiles overlap heavily because the mechanism overlaps heavily. Sexual side effects — decreased libido, erectile changes, changes in ejaculate volume — are the ones that come up most often in clinical conversation. The trial-reported rates for both drugs are in the low single digits, with most men experiencing nothing. Real-world reporting tends to be higher than trial data, partly because forums concentrate the men who experience side effects and partly because trials use blinded reporting that washes out some of the noise.
Whether dutasteride causes more side effects than finasteride is debated and probably overstated in practice. In the head-to-head trial referenced above, the two drugs had comparable side-effect rates. Some clinicians believe dutasteride's deeper DHT suppression should mean a higher chance of side effects, and the long half-life means that if a side effect does emerge, it takes longer to clear after stopping. Others note that the trial evidence does not consistently show a clinically meaningful difference.
Post-finasteride syndrome — a contested cluster of persistent symptoms that some men report after stopping finasteride — is the loudest concern in the online conversation. It is real for the men who experience it; the question of how common it is, and whether dutasteride carries similar risk, is unsettled in the medical literature. A clinician should walk through the current state of the evidence honestly rather than dismissing the question or amplifying it. The FDA's safety page on finasteride covers the official position.
Cost and access: what affects pricing
Generic finasteride is cheap. Cash-pay pricing for 1mg generic finasteride is typically in the $15 to $30 per month range, sometimes lower through telehealth subscriptions or pharmacy discount programs. Brand-name Propecia exists but offers nothing clinically different from the generic at substantially higher cost.
Generic dutasteride is also available — it lost patent protection in 2015 — and runs roughly $30 to $60 per month at most pharmacies, depending on whether the prescription is for the BPH-approved 0.5mg dose or compounded for hair loss. Some telehealth programs price compounded dutasteride higher because of the off-label compounding step.
Insurance coverage is uneven for both. Most plans do not cover hair loss medications because androgenic alopecia is treated as cosmetic. Both drugs are commonly paid out of pocket, and the cost difference between them, while real, is usually not the deciding factor in the conversation.
Find out if this is right for you.
The Maro intake takes about five minutes. A licensed physician reviews your case before any prescription is issued — no rubber stamps.
Start Your Free VisitWho might consider dutasteride instead of finasteride?
Three situations come up most often. The first is a man who has been on finasteride for a year or more, has been consistent, and feels the response has plateaued or is not delivering enough. Switching to dutasteride is one of the moves a clinician might suggest in that case, alongside other adjustments like adding or optimizing minoxidil.
The second is a man with significant crown thinning specifically. The crown tends to respond a bit more to deeper DHT suppression than the hairline does, and dutasteride's edge over finasteride shows up most clearly in crown density.
The third is a man who has done the homework, understood the trade-offs, and decided he wants to start with the more aggressive option from the beginning. This is more common in men who are starting treatment later, when the timeline for visible change feels shorter, or who are dealing with rapidly progressive thinning.
What a clinician will not usually recommend is dutasteride as a casual upgrade for a man who has been on finasteride for two months and decided it is not working. Two months is too early to evaluate either drug. The default recommendation in most cases is to stay the course on finasteride for at least a year before reassessing, because that is how long the visible effect actually takes to develop.
Why clinician review matters
Both drugs are prescription-only for a reason. Neither is appropriate for all men. The screening conversation covers prostate health (these drugs lower PSA, which can mask early prostate signals if not interpreted in context), liver function, current medications, fertility plans (DHT plays a role in male reproductive function and any 5-ARI affects this), and history of mood-related side effects. Anyone planning to father children in the near future should have a specific conversation about that timing — it is not a hard contraindication, but it is a relevant consideration.
A real intake is also where the question of starting at all gets sorted. Some men assume they need a 5-alpha-reductase inhibitor when minoxidil alone, paired with a few lifestyle changes, would have been enough. Others assume they cannot tolerate finasteride based on what they read online, when the actual statistical risk is small and worth weighing. Maro's intake involves a licensed physician walking through these questions and signing off before any prescription is issued.
Frequently asked questions
Is dutasteride better than finasteride for hair loss?
Dutasteride produces somewhat better results on average in head-to-head trials, particularly for crown density, because it suppresses DHT more deeply. The difference is real but modest — usually a matter of incremental improvement rather than a categorical upgrade. For most men, finasteride is the right starting point, and dutasteride becomes a consideration if finasteride does not deliver enough or if a clinician determines the marginal benefit is worth pursuing.
Can you switch from finasteride to dutasteride?
Yes, switching is reasonable when finasteride has been tried consistently for at least a year and the response is incomplete. The transition does not require a washout period — clinicians typically stop finasteride and start dutasteride directly. Because dutasteride has a long half-life, full DHT suppression takes a few weeks to settle in. Any switch should happen under clinician guidance with attention to side-effect monitoring during the transition.
Does dutasteride have more side effects than finasteride?
In direct trial comparisons, the side-effect rates have been broadly similar, though dutasteride's deeper DHT suppression and longer half-life mean that side effects, when they occur, can take longer to clear after stopping. Online reporting tends to suggest dutasteride is harsher, but the controlled-trial evidence does not consistently support that. Both drugs have similar profiles overall and the same screening considerations.
How long should you stay on finasteride before switching to dutasteride?
Most clinicians recommend at least 12 months on consistent finasteride before considering a switch, because that is how long it takes to see the full effect of the medication. Earlier evaluations tend to underestimate response. If after a full year the result is clearly insufficient, a switch to dutasteride or the addition of other treatments is a reasonable next step.
Is dutasteride FDA-approved for hair loss?
No, dutasteride is FDA-approved for benign prostatic hyperplasia, not for hair loss. Its use for male pattern baldness is off-label in the United States. It is approved for hair loss in South Korea and Japan, where it has been used clinically for years. Off-label use in the US is legal and common when prescribed by a licensed clinician for a clinically appropriate reason.
Researched and written by The Maro Care Team and reviewed by a licensed physician through our clinical partner network. Maro provides telehealth-based men's health care across hair loss, ED, GLP-1 weight loss, and performance. Last reviewed: May 2026.


